Avricore Health Makes the Grade on 2023 TSX Venture 50
February 21, 2023 10:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Feb. 21, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) has been honoured by being named as one of the 2023 Venture 50, the TSX...
Avricore Health Reports Second-Quarter 2022 Results
August 29, 2022 08:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Aug. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is pleased to provide this corporate update on the Company’s Q2 results. ...
Health Monitor Network® Appoints Key Sales Leader as Part of the Company’s Continued Growth Strategy
August 23, 2022 09:00 ET
|
Health Monitor Network
Montvale, NJ, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Health Monitor Network®, a nationally recognized targeted healthcare marketing platform for the biopharmaceutical/OTC industry, today announced the...
Medical Communications Company, Allm, Raises About $180M
July 11, 2022 08:00 ET
|
ALLM North America
CAMBRIDGE, Mass., July 11, 2022 (GLOBE NEWSWIRE) -- Mobile medical communications company, ALLM, successfully completed about $180M financing through a third-party allotment of new shares to DeNA...
Hemex Health and Mylab Discovery Solutions Launch Gazelle™ PathoCatch™ COVID-19 FIA Test
July 06, 2022 08:00 ET
|
Hemex Health
PORTLAND, Ore. and PUNE, India, July 06, 2022 (GLOBE NEWSWIRE) -- Mylab Discovery Solutions, India’s leading biotechnology company, and Portland, OR-based Hemex Health, a medical diagnostic device...
Hemex Health announces breakthrough measurement capability for clinicians monitoring sickle cell disease therapy
May 08, 2022 06:00 ET
|
Hemex Health
PORTLAND, Ore. and MUMBAI, India, May 08, 2022 (GLOBE NEWSWIRE) -- Hemex Health, a Portland, Oregon-based health-tech startup, announced a significant enhancement to their Gazelle™ Hb Variant test,...
Point of Care and Rapid Diagnostics Market worth $72.0 billion by 2027 - Exclusive Report by MarketsandMarkets™
April 04, 2022 14:20 ET
|
MarketsandMarkets™
Northbrook, April 04, 2022 (GLOBE NEWSWIRE) -- According to the new market research report "Point of Care and Rapid Diagnostics Market by Product (Glucose, Infectious Disease(HIV, Hepatitis C),...
HealthTab™ to Offer Abbott’s i-STAT Alinity™, Expanding Chronic Disease Testing to Select Community Pharmacies in Canada
November 23, 2021 07:30 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Nov. 23, 2021 (GLOBE NEWSWIRE) -- Avricore Health Inc. (TSXV: AVCR, OTC: AVCRF) (“Avricore Health” or the “Company”) is pleased to announce the signing of a...
Talis Biomedical Granted FDA Emergency Use Authorization (EUA) for COVID-19 Molecular Point-of-Care Test to Detect SARS-CoV-2
November 08, 2021 08:00 ET
|
Talis Biomedical Corporation
Authorized for use in a variety of healthcare and congregate settings, Talis One™ enables lab-quality results without the wait to detect or rule out COVID-19 in less than 30 minutes Talis One’s...
HealthTab™ Expands to British Columbia in Select Shoppers Drug Mart® Locations
October 26, 2021 08:00 ET
|
Avricore Health Inc.
VANCOUVER, British Columbia, Oct. 26, 2021 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) announces that it has expanded patient testing with the HealthTab™ platform...